Potential reasons for this variation between countries in incidence rates may relate to differences in cancer registration practices, diagnostic practices (e.g. prostate specific antigen testing for prostate cancer), environment, genetic factors or lifestyle factors such as diet and physical activity [2]. This evidence concerns the gene KLK3 and prostate carcinoma.